8-144360355-C-A

Variant summary

Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_Strong

The NM_001363118.2(SLC52A2):​c.863C>A​(p.Ala288Glu) variant causes a missense change. The variant allele was found at a frequency of 0.000000687 in 1,456,170 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A288V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

SLC52A2
NM_001363118.2 missense

Scores

5
10
3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 4.89

Publications

0 publications found
Variant links:
Genes affected
SLC52A2 (HGNC:30224): (solute carrier family 52 member 2) This gene encodes a membrane protein which belongs to the riboflavin transporter family. In humans, riboflavin must be obtained by intestinal absorption because it cannot be synthesized by the body. The water-soluble vitamin riboflavin is processed to the coenzymes flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD) which then act as intermediaries in many cellular metabolic reactions. Paralogous members of the riboflavin transporter gene family are located on chromosomes 17 and 20. Unlike other members of this family, this gene has higher expression in brain tissue than small intestine. Alternative splicing of this gene results in multiple transcript variants encoding the same protein. Mutations in this gene have been associated with Brown-Vialetto-Van Laere syndrome 2 - an autosomal recessive progressive neurologic disorder characterized by deafness, bulbar dysfunction, and axial and limb hypotonia. [provided by RefSeq, Jul 2012]
SLC52A2 Gene-Disease associations (from GenCC):
  • Brown-Vialetto-van Laere syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp, G2P, PanelApp Australia

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001363118.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.941

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001363118.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A2
NM_001363118.2
MANE Select
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5NP_001350047.1Q9HAB3
SLC52A2
NM_001253815.2
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5NP_001240744.1Q9HAB3
SLC52A2
NM_001253816.2
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5NP_001240745.1Q9HAB3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLC52A2
ENST00000643944.2
MANE Select
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5ENSP00000496184.2Q9HAB3
SLC52A2
ENST00000329994.7
TSL:1
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5ENSP00000333638.2Q9HAB3
SLC52A2
ENST00000402965.5
TSL:2
c.863C>Ap.Ala288Glu
missense
Exon 3 of 5ENSP00000385961.1Q9HAB3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.87e-7
AC:
1
AN:
1456170
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
724598
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47780
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111976
Other (OTH)
AF:
0.00
AC:
0
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Pathogenic
0.16
D
BayesDel_noAF
Uncertain
0.0
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.55
D
Eigen
Benign
0.19
Eigen_PC
Benign
-0.034
FATHMM_MKL
Uncertain
0.89
D
M_CAP
Pathogenic
0.45
D
MetaRNN
Pathogenic
0.94
D
MetaSVM
Benign
-0.41
T
MutationAssessor
Pathogenic
3.2
M
PhyloP100
4.9
PrimateAI
Uncertain
0.70
T
PROVEAN
Uncertain
-3.9
D
REVEL
Uncertain
0.39
Sift
Uncertain
0.0010
D
Sift4G
Uncertain
0.0020
D
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Varity_R
0.84
gMVP
0.88
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs764545993;
hg19: chr8-145584015;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.